深部脑刺激治疗强迫症:基于个体参与者结局数据的假刺激对照试验系统综述与Meta分析
该研究首次利用个体参与者结局数据对假刺激对照的随机对照试验进行Meta分析,共纳入9项小型RCT、91例患者,发现DBS较假刺激可显著降低YBOCS评分5.1分(95%CI 2.0-8.1),但证据质量低、异质性高,参数逐步优化策略可能影响疗效。
要点
- DBS较假刺激显著降低YBOCS评分5.1分(95%CI 2.0-8.1,Hedges g 0.56)。
- 应答OR为4.7(95%CI 1.8-12.2),NNT为3.9。
- 参数逐步优化策略与更好疗效相关(beta 5.1,95%CI 0.59-9.5,p=0.026)。
核心结论
- DBS治疗强迫症较假刺激有显著效应,但证据质量低且异质性高。
研究设计与样本
- 系统检索多个数据库,纳入所有比较DBS与假刺激的成人强迫症RCT,不限刺激靶点。
- 获取个体参与者YBOCS数据,采用两阶段随机效应Meta分析,并用GRADE评估证据质量。
- 共纳入9项小型RCT,总样本91例患者。
主要发现
- DBS较假刺激使YBOCS评分降低5.1分(95%CI 2.0-8.1,Hedges g 0.56)。
- 应答OR为4.7(95%CI 1.8-12.2),NNT为3.9。
- 采用DBS参数逐步调整至最大改善的策略与更好疗效相关(beta 5.1,95%CI 0.59-9.5,p=0.026)。
- 不良反应发生于手术、活性刺激和假刺激阶段及随访期,轻躁狂和认知问题为最常见刺激相关不良事件。
- GRADE证据质量评级为低。
关键数值与推荐
- 主要疗效指标为YBOCS评分变化,DBS组较假刺激组降低5.1分(95%CI 2.0-8.1)。
- 应答OR 4.7(95%CI 1.8-12.2),NNT 3.9。
- 参数优化策略效应beta 5.1(95%CI 0.59-9.5,p=0.026)。
- GRADE证据质量评为低。
临床怎么用
- 对于严重难治性强迫症,DBS可作为假刺激对照试验中显示优于假刺激的干预选项。
- 临床实施DBS时可采用参数逐步调整至最大改善的优化策略。
- 需关注手术期、刺激期及随访期的不良事件,尤其是轻躁狂和认知问题。
局限性
- 纳入试验样本量小,总样本仅91例。
- 证据质量按GRADE评为低,异质性高。
- 需更多严格设计的假刺激对照证据提高可信度。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Deep brain stimulation (DBS) is a neuromodulatory intervention for severe, treatment-refractory obsessive-compulsive disorder (OCD). We conducted the first meta-analysis using individual participant outcome data, systematically evaluating (1) efficacy of DBS compared to sham-stimulation in randomized controlled trials (RCTs), (2) adverse events and (3) methodological trial quality. METHODS: We conducted a systematic search across multiple databases, including all RCTs comparing DBS with sham in adults with OCD, regardless of stimulation target. We obtained Yale-Brown Obsessive-Compulsive Scale (YBOCS) data for individual participants and performed a two-stage random-effects meta-analysis. We evaluated trial quality using the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) approach. RESULTS: Nine RCTs with small sample sizes were included, resulting in a total sample of 91 patients. Meta-analysis showed a decrease of 5.1 YBOCS points in favor of DBS compared to sham (95% confidence interval, CI, 2.0-8.1, 0.56 Hedges' g). OR was 4.7, 95% CI 1.8-12.2), with a NNT of 3.9. Optimization strategy appeared to impact efficacy, in favor of trials using gradual adjustments of DBS parameters guiding towards maximal improvement (beta 5.1, 95% CI 0.59-9.5, p-value 0.026). Adverse events occurred during surgery, active- and sham trial phases, and follow-up, with hypomania and cognitive problems being the most frequently reported stimulation-related adverse events. GRADE quality of evidence was rated low. DISCUSSION: Concluding, we found a significant effect of DBS compared to sham in treating OCD. However, the quality of evidence was low, and heterogeneity was high. Additional, rigorous, sham-controlled evidence could further improve credibility of DBS for OCD. PROSPERO-REGISTRATION NUMBER: CRD42024546836.
引用
- Cohen SE, Niemeijer MJ, Zantvoord JB, et al. Deep brain stimulation for obsessive-compulsive-disorder: a systematic review and meta-analysis of individual participant outcome data from sham-controlled trials. Mol Psychiatry. 2025. PMID: 40579425. doi:10.1038/s41380-025-03092-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。